All stock lists
Immuneering Corp (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
Healthcare · Biotechnology
$3.52-$0.19 (-5.12%)
Insider Score
80/ 100
IMRX Insider Score
Bullish1 qualifying trade · 1 insider · $89.50K bought in the last 90 days
IMRX Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue Growth (YoY) | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | $5.06 M | $5.00 M | $4.68 M | $4.49 M | $4.50 M |
| R&D Expense | $20.72 M | $14.00 M | $10.65 M | $9.25 M | $10.87 M |
| Operating Expenses | $25.79 M | $19.00 M | $15.33 M | $13.75 M | $15.38 M |
| Operating Income | -$25.79 M | -$19.00 M | -$15.33 M | -$13.75 M | -$15.38 M |
| Pretax Income | -$24.19 M | -$17.27 M | -$13.46 M | -$11.58 M | -$14.96 M |
| Tax Provision | — | — | — | — | — |
| Net Income | -$24.19 M | -$17.27 M | -$13.46 M | -$11.58 M | -$14.96 M |
| EPS (Basic) | -$0.37 | -$0.27 | -$0.21 | -$0.18 | -$0.38 |
| EPS (Diluted) | -$0.37 | -$0.27 | -$0.21 | -$0.18 | -$0.38 |
| Shares Outstanding | 64.71 M | 64.70 M | 64.66 M | 64.59 M | 39.67 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
